3 most recent filings and news items mentioning ENTA. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/ENTA/news?limit=20"
Pull ENTA filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayEntera Bio Ltd. intends to sell securities to BVF Partners L.P. and its affiliates, through a private placement pursuant to Regulation D, Rule 506.
View filing at SEC.gov →Enanta Pharmaceuticals entered an agreement with Jefferies LLC to sell shares of its common stock through Jefferies as an agent. This flexible funding agreement allows the company to raise capital incrementally as needed.
View filing at SEC.gov →Enanta Pharmaceuticals announced advancement of zelicapavir into a registrational Phase 2b/3 clinical trial for high-risk RSV adults, with Phase 2b data expected in 2027, plus a pediatric Phase 2b trial starting in Q3 2026. The company estimates the oral RSV antiviral market oppo
View filing at SEC.gov →